← Back
$MIRM All transactions

Mirum Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$2.2M

Shares

40,000

Price

$55

Filed

Aug 8

Insider

Name

Peetz Christopher

Title

CHIEF EXECUTIVE OFFICER

CIK

0001614740

Roles

Director Officer

Transaction Details

Transaction Date

2025-08-07

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

138,641

Footnotes

Reported transaction occurred pursuant to a Rule 10b5-1 Plan adopted by the reporting person on November 22, 2024. | The weighted average sale price for the transaction reported was $55.251022, and the range of prices were between $55.25 and $55.485. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | The stock option is fully vested.

Filing Info

Accession No.

0001415889-25-021350

Form Type

4

Issuer CIK

0001759425

Peetz Christopher's History

Date Ticker Type Value
2026-02-02 MIRM $941K
2026-01-28 MIRM A $0
2026-01-28 MIRM A $0
2026-01-28 MIRM A $0
2026-01-26 MIRM $657K
2026-01-23 MIRM M
2026-01-23 MIRM M $0
2026-01-22 MIRM $662K
2026-01-21 MIRM M
2026-01-21 MIRM M $0

Other Insiders at MIRM (90d)

Insider Bought Sold Last
Heron Patrick J $9.0M 2026-01-23
BJERKHOLT ERIC
CHIEF FINANCIAL OFFICER
$101K 2026-01-28
Ramasastry Saira $194K 2026-04-15
Peetz Christopher
CHIEF EXECUTIVE OFFICER
$1.6M 2026-02-02
Radovich Peter
PRESIDENT AND COO
$574K 2026-02-02
Quan Joanne
CHIEF MEDICAL OFFICER
2026-01-28
Howe Jolanda
SVP, GLOBAL CONTROLLER
$181K 2026-02-02